u/paloma_stanescu

a non-peptide agonist does not degrade the way a peptide does

Daily dosing, so what does the exposure profile look like across the day?

This. The withdrawal data is not ambiguous and framing regain as a personal failure is both wrong and cruel.

Holding off on any opinion until phase 3 reports. That is not a satisfying position and it is the honest one.

Are you comparing doses across a small molecule and a peptide?

the habits are the part that has to outlive the dose

maintenance is where the logistics finally get boring, which is the point

Right, and comparing milligrams between a small molecule and a peptide is meaningless in either direction.

Interval stretching changes the exposure profile: with a week-long half-life, moving to ten or twelve days lowers trough concentration more than it lowers average exposure. That is why appetite return is often the first thing noticed.

None of this is a taper plan.

This reframing is the most useful thing on the board for anyone approaching this phase.

Small fix — you have described interval stretching and called it a dose reduction. The exposure profiles differ.

appetite returns before the scale acknowledges anything

None of this is a taper plan. What dose holds for you is a question for somebody with your history in front of them.

Disagree. You are comparing doses across a small molecule and a peptide, which is not a comparison of anything.

Appetite returning before the scale moves follows from the mechanism: the appetite effect is the proximal one and weight is the lagging integrated outcome.

appetite returns before the scale acknowledges anything

Agreed that a few kilos of drift is ordinary. Weight is not a fixed number even for people who have never taken anything.

Maintenance is the phase with the least published guidance and the most individual variation, which is precisely why board consensus here is worth less than usual.

monthly weigh-ins are enough at this stage

daily dosing changes adherence in both directions

Dose reduction and interval extension are different interventions. Halving the dose keeps the rhythm and lowers the level; stretching keeps the level and lowers the frequency, with a lower trough.

a few kilos of drift is not a relapse

do not assume reconstitution intuitions apply, there is nothing to reconstitute

The no-timing-restriction thing is the part I would care about most in practice, and it barely gets mentioned here.

the habits are the part that has to outlive the dose

This is the fact the whole board hangs on.

Agreed, and it is why the oral peptide comparison keeps misleading people.

I would not treat a two-kilo range as drift requiring action. That is ordinary weight variation.

This. The withdrawal data is not ambiguous and framing regain as a personal failure is both wrong and cruel.

do not chase the last two kilos with a dose increase

boring is the objective now

a few kilos of drift is not a relapse